Health Departments no longer solely dictate when drugs are listed for reimbursement. HCC can help you navigate the increasing role that finance departments have in drug listing.
Through our partnership with the Reformulary Group, HCC can provide real world data of your and your competitors drug in the public and private markets. HCC can then help you optimize your current and new drugs.
The single payer healthcare system is operated by physicians, yet governed by politicians. This unique situation creates control and management challenges. Understanding barriers to entry can help you best position your product for optimal access.